Current therapies for neuromuscular manifestations of paraneoplastic syndromes
- PMID: 16469274
- DOI: 10.1007/s11910-996-0012-0
Current therapies for neuromuscular manifestations of paraneoplastic syndromes
Abstract
The neuromuscular manifestations of paraneoplastic disorders result in diverse syndromes that may also occur in patients without cancer. In general, treatment of these disorders is the same whether or not there is an underlying malignancy. However, when the disorder is believed to be paraneoplastic, the main concern should be prompt detection and treatment of the tumor, as this has been shown to offer the best chance for neurologic stabilization or improvement. The paraneoplastic neuromuscular disorders can be divided into two main categories: those that are directly mediated by antibodies and those that are believed to result from other immune-mediated mechanisms, including cytotoxic T-cell responses with or without association with specific antibodies. For disorders in which the antibodies are pathogenic, therapy is aimed at removing the antibodies. For the other disorders, adjuvant therapies are for the most part empiric and include a variety of immunosuppressant and immunomodulatory agents.
Similar articles
-
Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment.Semin Neurol. 2003 Jun;23(2):215-24. doi: 10.1055/s-2003-41134. Semin Neurol. 2003. PMID: 12894387 Review.
-
Diagnosis and management of paraneoplastic neurologic disorders.Curr Treat Options Oncol. 2013 Dec;14(4):528-38. doi: 10.1007/s11864-013-0249-1. Curr Treat Options Oncol. 2013. PMID: 23900965 Free PMC article. Review.
-
Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU.Neurocrit Care. 2020 Feb;32(1):286-294. doi: 10.1007/s12028-019-00875-5. Neurocrit Care. 2020. PMID: 31732848 Review.
-
Immunotherapeutic approaches to paraneoplastic neurological disorders.Expert Opin Biol Ther. 2002 Apr;2(4):419-30. doi: 10.1517/14712598.2.4.419. Expert Opin Biol Ther. 2002. PMID: 11955279 Review.
-
[Immunotherapy for paraneoplastic neurological syndromes].Nihon Naika Gakkai Zasshi. 2008 Aug 10;97(8):1830-7. doi: 10.2169/naika.97.1830. Nihon Naika Gakkai Zasshi. 2008. PMID: 18833703 Review. Japanese. No abstract available.
Cited by
-
Progress in the management of paraneoplastic neurological disorders.Ther Adv Neurol Disord. 2010 Jan;3(1):43-52. doi: 10.1177/1756285609349521. Ther Adv Neurol Disord. 2010. PMID: 21180635 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical